Clinical and Experimental Dermatology最新文献

筛选
英文 中文
Successful treatment of lupus miliaris disseminatus faciei with topical ivermectin: a case report. 局部伊维菌素成功治疗面部传播性军事性狼疮1例。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf284
Carmen Cánovas Seva, Cecilia Tejero García, Brais Chao Maseda, Jose Saez Padilla, Carlos Aliste-Santos, Elena Roson
{"title":"Successful treatment of lupus miliaris disseminatus faciei with topical ivermectin: a case report.","authors":"Carmen Cánovas Seva, Cecilia Tejero García, Brais Chao Maseda, Jose Saez Padilla, Carlos Aliste-Santos, Elena Roson","doi":"10.1093/ced/llaf284","DOIUrl":"https://doi.org/10.1093/ced/llaf284","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unequal NHS wig provision: toupée or no toupée, that is the question? 不平等的国民保健服务假发供应:是否有顶装限期,这就是问题所在?
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf282
Marianne de Brito, Amy Johnson, Sue Schilling, Leila Asfour, Nick J Levell
{"title":"Unequal NHS wig provision: toupée or no toupée, that is the question?","authors":"Marianne de Brito, Amy Johnson, Sue Schilling, Leila Asfour, Nick J Levell","doi":"10.1093/ced/llaf282","DOIUrl":"https://doi.org/10.1093/ced/llaf282","url":null,"abstract":"<p><p>Wigs are a necessary medical orthotic for some with alopecia to participate in society. However, for those with limited incomes, government funded National Health Service (NHS) wig provision is of great help. Recent reports to Alopecia UK, a patient support group, suggest restrictions in this support. The availability of NHS wig provision by UK geographical region was assessed by surveying dermatology secondary care healthcare professionals. There were 75 responses from 48/136 (35%) of UK Trusts and Health Boards. It was difficult for clinicians at 24/48 (50%) institutions to prescribe wigs. Wig provision was impossible for 11%. There was regional variation; it was straightforward throughout Scotland and the South West of England but difficult in Northern Ireland and London, where 50% reported it was impossible or nearly impossible. This demonstrates unwarranted variation in wig prescription difficulty for patients across the UK.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study. 停用杜匹单抗后特应性皮炎的临床病程:一项多中心真实世界研究。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf275
Francesca Barei, Stefano Macchi, Paolo Calzari, Simone Ribero, Michela Ortoncelli, Caterina Foti, Anna Balato, Eugenia Veronica Di Brizzi, Ketty Peris, Niccolò Gori, Elena Ippoliti, Carlotta Gurioli, Bianca Maria Piraccini, Ilaria Trave, Emanuele Cozzani, Elena Pezzolo, Laura Bonzano, Enzo Errichetti, Natale Schettini, Eustachio Nettis, Massimo Gola, Nicola Milanesi, Claudio Feliciani, Maria Beatrice De Felici Del Giudice, Anna Campanati, Helena Gioacchini, Armando Pisapia, Gianluca Avallone, Giuseppe Micali, Maria Letizia Musumeci, Romina Ortega, Flavia Manzo Margiotta, Marco Romanelli, Katharina Hansel, Luca Stingeni, Cataldo Patruno, Maria Esposito, Maria Concetta Fargnoli, Andrea De Berardinis, Caterina Ferreli, Laura Calabrese, Pietro Rubegni, Laura Lazzeri, Laura Grigolato, Benedetta Galli, Mariateresa Rossi, Martina Maurelli, Giampiero Girolomoni, Giuseppe Lauletta, Maddalena Napolitano, Angela Alfano, Luigi Gargiulo, Alessandra Narcisi, Angelo Valerio Marzano, Silvia Mariel Ferrucci
{"title":"Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study.","authors":"Francesca Barei, Stefano Macchi, Paolo Calzari, Simone Ribero, Michela Ortoncelli, Caterina Foti, Anna Balato, Eugenia Veronica Di Brizzi, Ketty Peris, Niccolò Gori, Elena Ippoliti, Carlotta Gurioli, Bianca Maria Piraccini, Ilaria Trave, Emanuele Cozzani, Elena Pezzolo, Laura Bonzano, Enzo Errichetti, Natale Schettini, Eustachio Nettis, Massimo Gola, Nicola Milanesi, Claudio Feliciani, Maria Beatrice De Felici Del Giudice, Anna Campanati, Helena Gioacchini, Armando Pisapia, Gianluca Avallone, Giuseppe Micali, Maria Letizia Musumeci, Romina Ortega, Flavia Manzo Margiotta, Marco Romanelli, Katharina Hansel, Luca Stingeni, Cataldo Patruno, Maria Esposito, Maria Concetta Fargnoli, Andrea De Berardinis, Caterina Ferreli, Laura Calabrese, Pietro Rubegni, Laura Lazzeri, Laura Grigolato, Benedetta Galli, Mariateresa Rossi, Martina Maurelli, Giampiero Girolomoni, Giuseppe Lauletta, Maddalena Napolitano, Angela Alfano, Luigi Gargiulo, Alessandra Narcisi, Angelo Valerio Marzano, Silvia Mariel Ferrucci","doi":"10.1093/ced/llaf275","DOIUrl":"https://doi.org/10.1093/ced/llaf275","url":null,"abstract":"<p><strong>Introduction: </strong>Limited data exist on the clinical course of atopic dermatitis (AD) after the discontinuation of dupilumab. This study aims to assess disease progression following dupilumab discontinuation.</p><p><strong>Methods: </strong>A multicenter, retrospective study was conducted on 208 patients with severe AD who discontinued dupilumab for reasons unrelated to inefficacy. The Eczema Area and Severity Index (EASI), Pruritus Numerical Rating Scale (P-NRS), Atopic Dermatitis Control Tool (ADCT), and Dermatology Life Quality Index (DLQI) were used to assess disease activity post-discontinuation. Kaplan-Meier analysis estimated the time and probability of disease worsening (defined as EASI >7.0, EASI increase ≥6.6, P-NRS ≥4, P-NRS increase ≥4, ADCT ≥7, ADCT increase ≥5, or DLQI increase ≥4), as well as the need to restart systemic treatment.</p><p><strong>Results: </strong>The main reasons for discontinuing dupilumab were clinical remission or good clinical control (43.3%), patient 'decision (11.1%), and pregnancy or pregnancy's desire (20.7%). Patients with a family history of AD or non-classical phenotypes had a significantly higher likelihood of disease worsening. A significant portion (42.8%) of patients resumed systemic treatment, within a median time of 47 weeks, and a baseline median EASI score of 10.0 and a median P-NRS of 6.0. The probability of resuming systemic treatment was 25% at 31 weeks and 50% at 94 weeks. Re-initiation of dupilumab significantly improved EASI and P-NRS scores within 16 weeks.</p><p><strong>Conclusion: </strong>Discontinuing dupilumab is associated with disease recurrence in some patients, especially those with a family history or non-classical AD. Dupilumab re-initiation is effective, leading to significant clinical improvements and supporting its use after treatment interruption.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Ten-year Retrospective Study of 103 Cases. 药物致Stevens-Johnson综合征和中毒性表皮坏死松解103例10年回顾性分析。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf278
Lu Zhou, Yun Lu, Ya Zou, Hua Wei, Xirui Guo, Qinchuan Li, Yan Zhou, Xiaotian Zhao, Fangqing Xie, Liwen Zhang
{"title":"Drug-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Ten-year Retrospective Study of 103 Cases.","authors":"Lu Zhou, Yun Lu, Ya Zou, Hua Wei, Xirui Guo, Qinchuan Li, Yan Zhou, Xiaotian Zhao, Fangqing Xie, Liwen Zhang","doi":"10.1093/ced/llaf278","DOIUrl":"https://doi.org/10.1093/ced/llaf278","url":null,"abstract":"<p><strong>Background: </strong>Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, life-threatening conditions with high mortality, most frequently caused by drugs.</p><p><strong>Methods: </strong>A retrospective study was reviewed at a tertiary hospital in China during the period of 2013 to 2023. The aim of this study was to evaluate and compare the demographic, laboratory and clinical features, culprit drugs, complications, treatment and outcome of drug-induced SJS/TEN patients.</p><p><strong>Results: </strong>The study population included 54 SJS patients, 17 SJS-TEN overlap patients, and 32 TEN patients. The average age was 49.0±21.5 years (range: 1-90 years). Females were predominant, with a female to male ratio of 1.34:1. Antibiotics (34.0%), non-steroidal anti-inflammatory drugs (NSAIDs) (16.5%), and anticonvulsants (14.6%) were the most frequently implied drug categories, with carbamazepine, levofloxacin, ibuprofen, aspirin, amoxicillin, metronidazole and lamotrigine being the most common individual causative drugs. In addition to mucosal involvement, liver dysfunction, pneumonia, and heart involvement were the most common complications of SJS/TEN. Almost all patients except one were treated with the systemic corticosteroid treatment, and 47.6% of patients received intravenous immunoglobulin (IVIG) combined with steroid therapy. The mortality rate was 9.7% overall, with the highest mortality in the TEN group, at 15.6%. Moreover, there was no statistical difference between the predicted and actual mortality (12.6% vs. 9.7%) (P=0.507).</p><p><strong>Conclusions: </strong>In our study, carbamazepine, levofloxacin, ibuprofen, aspirin, amoxicillin, metronidazole and lamotrigine were the most common triggers for SJS/TEN. If combined with high-risk factors such as pneumonia, renal insufficiency, gastro-intestinal disorder, cardiac involvement and sepsis, SJS/TEN patients might have a higher risk of mortality.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early-onset extensive seborrheic keratoses in the spectrum of familial acanthosis nigricans. 家族性黑棘皮病谱系中的早发性广泛脂溢性角化病。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf273
David Pesqué, Beatriz Bellosillo, Álvaro March-Rodríguez, Irene Abreu-Rodriguez, Luis A Pérez-Jurado, Ramon M Pujol
{"title":"Early-onset extensive seborrheic keratoses in the spectrum of familial acanthosis nigricans.","authors":"David Pesqué, Beatriz Bellosillo, Álvaro March-Rodríguez, Irene Abreu-Rodriguez, Luis A Pérez-Jurado, Ramon M Pujol","doi":"10.1093/ced/llaf273","DOIUrl":"https://doi.org/10.1093/ced/llaf273","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of alpha-HPV types in cutaneous squamous cell carcinoma associated with markers of carcinogenesis: a retrospective study. 在与癌变标志物相关的皮肤鳞状细胞癌中检测α - hpv类型:一项回顾性研究。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf264
Florence Brunet-Possenti, Morgane Weiss, Jean-Luc Prétet, Lydia Deschamps, Vincent Descamps, Caroline Halimi, Diane Descamps, Jade Ghosn, Romane Guilbaud, Charlotte Charpentier, Valentine Marie Ferré
{"title":"Detection of alpha-HPV types in cutaneous squamous cell carcinoma associated with markers of carcinogenesis: a retrospective study.","authors":"Florence Brunet-Possenti, Morgane Weiss, Jean-Luc Prétet, Lydia Deschamps, Vincent Descamps, Caroline Halimi, Diane Descamps, Jade Ghosn, Romane Guilbaud, Charlotte Charpentier, Valentine Marie Ferré","doi":"10.1093/ced/llaf264","DOIUrl":"https://doi.org/10.1093/ced/llaf264","url":null,"abstract":"<p><strong>Background: </strong>While the role of oncogenic alpha (α)-HPVs in anogenital and oral mucosal cancers is well-established, their involvement in skin carcinogenesis remains unexplored.</p><p><strong>Objective: </strong>To investigate the role of α-HPV in cutaneous squamous cell carcinoma (cSCC).</p><p><strong>Methods: </strong>This retrospective study included 129 formalin-fixed, paraffin-embedded cSCC samples. The main outcomes were the proportion of α-HPV positive cSCC and the characterization of viral features, assessed through HPV typing and viral DNA integration analysis.</p><p><strong>Results: </strong>The study included 99 cases of invasive cSCCs and 30 Bowen's disease. HPV DNA was detected in 56.6% of samples. HPV from the α genus were identified in 25 samples, (19.4%), with only a single α-HPV type detected in each positive sample. HPV16 was the main type, detected in 10 samples. Peripheral healthy skin tested negative in 10 out of 11 α-HPV-positive samples. Viral DNA was integrated in host-cell DNA in 8 out of 9 HPV16-positive samples.</p><p><strong>Conclusions: </strong>This study highlights a significant prevalence of α-HPV-positive samples among both invasive and in situ cSCC. The virological findings support a carcinogenic role of α-HPV in cSCC.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bipolar Syndrome Among Patients with Psoriasis: A Nested Case-Control Propensity-Scored Study. 银屑病患者双相情感障碍:一项巢式病例对照倾向评分研究。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf283
Amritpal Kooner, Rawle A Sekhon, Beniamin Zeka, Michelle Anthony
{"title":"Bipolar Syndrome Among Patients with Psoriasis: A Nested Case-Control Propensity-Scored Study.","authors":"Amritpal Kooner, Rawle A Sekhon, Beniamin Zeka, Michelle Anthony","doi":"10.1093/ced/llaf283","DOIUrl":"https://doi.org/10.1093/ced/llaf283","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapidly Growing Neck mass in a young woman. 年轻女性颈部快速增长的肿块。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf213
Bing-Sian Lin, Kuang-Ling Ou, Chien-Ping Chiang
{"title":"Rapidly Growing Neck mass in a young woman.","authors":"Bing-Sian Lin, Kuang-Ling Ou, Chien-Ping Chiang","doi":"10.1093/ced/llaf213","DOIUrl":"https://doi.org/10.1093/ced/llaf213","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cutaneous horn in a male patient with well-controlled HIV. 艾滋病毒控制良好的男性患者的皮肤角。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-20 DOI: 10.1093/ced/llaf277
Charlotte Muehlschlegel, Aparna Vyas, Claire Martyn-Simmons, Nathan Asher, Evangelia Panagou
{"title":"A cutaneous horn in a male patient with well-controlled HIV.","authors":"Charlotte Muehlschlegel, Aparna Vyas, Claire Martyn-Simmons, Nathan Asher, Evangelia Panagou","doi":"10.1093/ced/llaf277","DOIUrl":"https://doi.org/10.1093/ced/llaf277","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intralesional sodium thiosulfate is an effective treatment for non-uraemic calciphylaxis. 局部注射硫代硫酸钠是治疗非尿毒性钙化的有效方法。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-06-19 DOI: 10.1093/ced/llaf254
Wen Hao Tan, Joel Hua Liang Lim
{"title":"Intralesional sodium thiosulfate is an effective treatment for non-uraemic calciphylaxis.","authors":"Wen Hao Tan, Joel Hua Liang Lim","doi":"10.1093/ced/llaf254","DOIUrl":"https://doi.org/10.1093/ced/llaf254","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144511578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信